Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors Meeting Abstract


Authors: Autio, K. A.; Arkenau, H. T.; O'Neil, B. H.; Bendell, J. C.; El-Khoueiry, A.; Strauss, J.; Weise, A.; Uboha, N. V.; Rizvi, N. A.; Zheng, B.; Desnoyers, L.; Stroh, M.; Carman, L.; Humphrey, R. W.; Will, M.; Boni, V.; Spira, A. I.; Naing, A.
Abstract Title: Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 154s
Language: English
ACCESSION: WOS:000442916001443
DOI: 10.1200/JCO.2018.36.15_suppl.3071
PROVIDER: wos
Notes: Meeting Abstract: 3071 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    119 Autio